mounjaro glp-1 (Tirzepatide): Raising the Bar for Treatments – Nutri-Align Mounjaro dominates GLP-1 segment that

For health professionals, understanding the range of strategies patients are exploring, as well as the evidence (or lack thereof) behind them, is vital to guiding safe and effective care

Iron deficiency and anaemia in women

The analysis showed that metabolic surgery significantly reduced major adverse cardiovascular events over 3.9 years of follow-up, with a hazard ratio of 0.61

TOLERABILITY AND ADVERSE EVENTS The most common adverse events associated with GLP-1 receptor agonist use in general are gastrointestinal in nature, with mild-to-moderate diarrhea, nausea, and vomiting being the most commonly reported events

H.et al (2023)